Customs exemption amendment adds rifampicin and rifampicin INH formulations to notification and omits a prior entry. The Central Government, invoking statutory powers under the Customs Act, amends two customs exemption notifications: it omits Sl. No. 9 and its entry from Notification No. 45/79-Customs, and inserts a new Sl. No. into Notification No. 213/88-Customs to list Rifampicin and rifampicin capsules/syrup/tablets and rifampicin INH capsules/tablets as covered items.
Cases where this provision is explicitly mentioned in the judgment/order text; may not be exhaustive. To view the complete list of cases mentioning this section, Click here.
Provisions expressly mentioned in the judgment/order text.
Customs exemption amendment adds rifampicin and rifampicin INH formulations to notification and omits a prior entry.
The Central Government, invoking statutory powers under the Customs Act, amends two customs exemption notifications: it omits Sl. No. 9 and its entry from Notification No. 45/79-Customs, and inserts a new Sl. No. into Notification No. 213/88-Customs to list Rifampicin and rifampicin capsules/syrup/tablets and rifampicin INH capsules/tablets as covered items.
Full Summary is available for active users!
Note: It is a system-generated summary and is for quick reference only.